An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT02750514. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Fast Real Time Assessment of Combination Therapies in Immuno-Oncology Study in Subjects With Advanced Non-Small Cell Lung Cancer (FRACTION-Lung)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether Nivolumab, in combination with other therapies, is effective in patients with advanced Non-Small Cell lung cancer
Study identification
- NCT ID
- NCT02750514
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 295 participants
Conditions and interventions
Conditions
Interventions
- Nivolumab Biological
- Dasatinib Drug
- Relatlimab Biological
- Ipilimumab Biological
- BMS-986205 Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 9, 2016 (Actual)
- Primary completion
- Jan 29, 2020 (Actual)
- Completion
- Jan 29, 2020 (Actual)
- Last update posted
- Mar 22, 2021
2016 – 2020
United States locations
- U.S. sites
- 35
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| University of Southern California (USC) | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of Californa, Los Angeles (UCLA) | Los Angeles | California | 90095 | — |
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92658 | — |
| University of California San Diego | San Diego | California | 92122 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Yale Cancer Center | New Haven | Connecticut | 06511 | — |
| University of Kansas Cancer Center | Westwood | Kansas | 66205 | — |
| University of Maryland - Marlene and Stewart Greenebaum Cancer Center | Baltimore | Maryland | 21201 | — |
| Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21287 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Dana Farber/Harvard Cancer Center | Boston | Massachusetts | 02215 | — |
| University of Michigan Health System (UMHS) - University Hospital (University of Michigan Medical Ce | Ann Arbor | Michigan | 48109 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Washington University, The Center for Advanced Medicine | St Louis | Missouri | 63110 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89119 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| Univ of NC Shool of Medicine | Chapel Hill | North Carolina | 27514 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Northwest Cancer Specialists | Portland | Oregon | 97225 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111-2497 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15217 | — |
| The West Clinic, P.C. d/b/a West Cancer Center | Germantown | Tennessee | 38138 | — |
| Sarah Cannon Cancer Center | Nashville | Tennessee | 37203 | — |
| Sammons Cancer Center (Uso) | Dallas | Texas | 75246 | — |
| Texas Oncology, P.A. | Fort Worth | Texas | 76104 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Us Oncology | Tyler | Texas | 75702 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | — |
| University of Washington-Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02750514, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 22, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02750514 live on ClinicalTrials.gov.